Literature DB >> 28702721

Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism.

P A Slominsky1, M I Shadrina1, T A Kolomin1, A V Stavrovskaya2, E V Filatova3, L A Andreeva1, S N Illarioshkin2, N F Myasoedov1.   

Abstract

Parkinson's disease (PD) is the second most common severe neurodegenerative disorder that is characterized by progressive degeneration of dopaminergic neurons (DA neurons) in the substantia nigra pars compacta (SNpc) region of the brain. In the present study, we investigated the effects of the synthetic regulatory peptides Semax (analog of an ACTH 4-10 fragment (ACTH4-10)) and Selank (analog of immunomodulatory taftsin) on behavior of rats with 6-hydroxidopamine (6-OHDA) induced PD-like parkinsonism. It was showed that both peptides did not affect motor activity of rats in elevated cross shaped maze and passive defensive behavior of the animals. At the same time, Selank decreased level of anxiety of rats with toxic damage of DA neurons in elevated cross shaped maze. Previously such effects of Selank were revealed in healthy rodents (rats and mice) with different models of psycho-emotional stress. Therefore, toxic damage of substantia nigra does not affect the response of the rat organism on this peptide.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28702721     DOI: 10.1134/S0012496617030048

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN: 0012-4966


  14 in total

1.  The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats.

Authors:  I I Kozlovskii; N D Danchev
Journal:  Neurosci Behav Physiol       Date:  2003-09

2.  Effects of Semax on dopaminergic and serotoninergic systems of the brain.

Authors:  K O Eremin; V S Kudrin; I A Grivennikov; N F Miasoedov; K S Rayevsky
Journal:  Dokl Biol Sci       Date:  2004 Jan-Feb

3.  Neuroprotective and antiamnesic effects of Semax during experimental ischemic infarction of the cerebral cortex.

Authors:  G A Romanova; D N Silachev; F M Shakova; Yu N Kvashennikova; I V Viktorov; S I Shram; N F Myasoedov
Journal:  Bull Exp Biol Med       Date:  2006-12       Impact factor: 0.804

Review 4.  [Regulatory peptides. A functional continuum].

Authors:  I P Ashmarin; M F Obukhova
Journal:  Biokhimiia       Date:  1986-04

5.  The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: a pilot study.

Authors:  Vasily V Stavchansky; Vadim V Yuzhakov; Alexandra Yu Botsina; Veronika I Skvortsova; Lyubov N Bondurko; Marina G Tsyganova; Svetlana A Limborska; Nikolay F Myasoedov; Lyudmila V Dergunova
Journal:  J Mol Neurosci       Date:  2010-07-09       Impact factor: 3.444

6.  [The role of opioid system in peculiarities of anti-anxiety effect of peptide anxiolytic selank].

Authors:  I I Kozlovskiĭ; L A Andreeva; M M Kozlovskaia; A V Nadorova; L G Kolik
Journal:  Eksp Klin Farmakol       Date:  2012

7.  [Effects of heptapeptide selank on the content of monoamines and their metabolites in the brain of BALB/C and C57Bl/6 mice: a comparative study].

Authors:  V B Narkevich; V S Kudrin; P M Klodt; A A Pokrovskiĭ; M M Kozlovskaia; A I Maĭskiĭ; K S Raevskiĭ
Journal:  Eksp Klin Farmakol       Date:  2008 Sep-Oct

8.  [Immunomodulatory effects of selank in patients with anxiety-asthenic disorders].

Authors:  O N Uchakina; P N Uchakin; N F Miasoedov; L A Andreeva; V E Shcherbenko; M V Mezentseva; M V Gabaeva; O Iu Sokolov; A A Zozulia; F I Ershov
Journal:  Zh Nevrol Psikhiatr Im S S Korsakova       Date:  2008

9.  [Effects of chronic Semax administration on exploratory activity and emotional reaction in white rats].

Authors:  D A Vilenskiĭ; N G Levitskaia; L A Andreeva; L Iu Alfeeva; A A Kamenskiĭ; N F Miasoedov
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  2007-06

10.  Selank and short peptides of the tuftsin family in the regulation of adaptive behavior in stress.

Authors:  M M Kozlovskaya; I I Kozlovskii; E A Val'dman; S B Seredenin
Journal:  Neurosci Behav Physiol       Date:  2003-11
View more
  1 in total

1.  Antrodia camphorata polysaccharide resists 6-OHDA-induced dopaminergic neuronal damage by inhibiting ROS-NLRP3 activation.

Authors:  Chenyang Han; Heping Shen; Yi Yang; Yongjia Sheng; Jin Wang; Wenyan Li; Xiaohong Zhou; Li Guo; Liping Zhai; Qiaobing Guan
Journal:  Brain Behav       Date:  2020-09-09       Impact factor: 3.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.